About MUSC Urology Ambulatory Care
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at MUSC Urology Ambulatory Care
During the past decade, MUSC Urology Ambulatory Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone
2009-04-29
2012-02-07
Completed
59
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
2010-09-16
2019-02-14
Completed
1,717
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MUSC Urology Ambulatory Care"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at MUSC Urology Ambulatory Care
According to Clinical.Site data, the most researched conditions in "MUSC Urology Ambulatory Care" are
"Neoplasm Metastasis" (1 trials), "Palliative Care" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "MUSC Urology Ambulatory Care" in a lesser frequency.
Clinical Trials Intervention Types at MUSC Urology Ambulatory Care
Most popular intervention types in "MUSC Urology Ambulatory Care" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Enzalutamide" (1 trials), "IV Placebo for tanezumab" (1 trials), "Placebo" (1 trials) and "Tanezumab 10 mg IV" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MUSC Urology Ambulatory Care
The vast majority of trials in "MUSC Urology Ambulatory Care" are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at MUSC Urology Ambulatory Care
Currently, there are NaN active trials in "MUSC Urology Ambulatory Care".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in MUSC Urology Ambulatory Care,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MUSC Urology Ambulatory Care, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".